This inventor holds 1 USPTO granted patent. Top assignee: Plus Chemicals, B.v.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Mieke Ivanova Sibeyn: Innovator in Semi-Synthetic Statins
Introduction
Mieke Ivanova Sibeyn is a prominent inventor based in Amersfoort, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly in the production of semi-synthetic statins. Her innovative work has the potential to enhance the efficiency of statin production, which is crucial for managing cholesterol levels in patients.
Latest Patents
Mieke holds a patent for a process titled "Process for the production of semi-synthetic statins via novel intermediates." This patent outlines a method for producing semi-synthetic statins, such as simvastatin, with a high yield. The process also includes the development of novel intermediate compounds that are essential for the production of these statins. This innovation is particularly beneficial as it utilizes naturally occurring statins, like lovastatin, as starting materials.
Career Highlights
Mieke is currently employed at Plus Chemicals B.V., where she continues to advance her research in pharmaceutical chemistry. Her work has garnered attention for its practical applications in the healthcare industry, particularly in the development of more effective cholesterol-lowering medications.
Collaborations
Mieke collaborates with notable colleagues, including Ton Rene Vries and Hans Wijnberg. Their combined expertise contributes to the innovative environment at Plus Chemicals B.V., fostering advancements in pharmaceutical research.
Conclusion
Mieke Ivanova Sibeyn is a trailblazer in the field of pharmaceutical innovation, particularly in the production of semi-synthetic statins. Her contributions are paving the way for more efficient and effective treatments for patients with high cholesterol.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile